Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Wave Life Sciences Ltd. (NASDAQ: WVE)
WVE Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-8.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
WVE Stock Analysis
WVE
PE Ratio:
WVE
PEG Ratio:
Not Available
WVE
Forward EPS Growth (12 month):
0.00%
WVE
PS Ratio:
15.4
WVE
PSG Ratio:
Not Available
WVE
Forward Revenue Growth (12 month):
0.00%
WVE Articles
No data was found